login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
AGIOS PHARMACEUTICALS INC (AGIO) Stock News
USA
- NASDAQ:AGIO -
US00847X1046
-
Common Stock
37.87
USD
-0.32 (-0.84%)
Last: 9/23/2025, 8:00:00 PM
37.87
USD
0 (0%)
After Hours:
9/23/2025, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AGIO Latest News, Press Relases and Analysis
All
Press Releases
20 days ago - By: Chartmill
- Mentions:
AEO
NCI
CAL
AIHS
...
Top movers in Thursday's pre-market session
13 hours ago - By: Benzinga
- Mentions:
PBM
MTNB
HSDT
SSKN
...
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
8 days ago - By: Schall Law Firm
AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation With the Schall Law Firm
9 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIO
10 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
13 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIO
15 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
18 days ago - By: Zacks Investment Research
- Mentions:
ADPT
ALLO
AKRO
AGIO Stock Falls as FDA Delays Decision on Pyrukynd for Thalassemia
19 days ago - By: Stocktwits
- Mentions:
VFMO
IWMW
Agios Pharma Stock Slumped 15% Today But Company Remains Top Pick For This Analyst – Find Out More
20 days ago - By: Agios Pharmaceuticals, Inc.
Agios Provides Update on U.S. PDUFA Goal Date for PYRUKYND® (mitapivat) in Thalassemia
20 days ago - By: Zacks Investment Research
- Mentions:
VRTX
Why Is Vertex (VRTX) Up 6.9% Since Last Earnings Report?
26 days ago - By: Yahoo Finance
- Mentions:
BAC
Agios Pharmaceuticals, Inc. (AGIO) Advances Pipeline With Tebapivat, AG-236 in Rare Blood Disorders
2 months ago - By: Stocktwits
Agios Retail Buzz Surges On Saudi Thalassemia Nod As Retail Hails ‘Incredible Recovery’ Despite FDA Concerns
2 months ago - By: Agios Pharmaceuticals, Inc.
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia
2 months ago - By: The Motley Fool
Agios (AGIO) Q2 Revenue Jumps 45%
2 months ago - By: Agios Pharmaceuticals, Inc.
Agios Reports Second Quarter 2025 Financial Results and Provides Business Update
2 months ago - By: Benzinga
- Mentions:
BSAC
BGC
RMNI
MTZ
...
Earnings Scheduled For July 31, 2025
2 months ago - By: Agios Pharmaceuticals, Inc.
Agios to Host Webcast Conference Call of Second Quarter Financial Results on July 31, 2025 at 8:00am ET
3 months ago - By: Agios Pharmaceuticals, Inc.
Agios Appoints Dr. Jay Backstrom to Board of Directors
3 months ago - By: Yahoo Finance
Agios Pharmaceuticals, Inc. (AGIO) Backed by TD Cowen for Mitapivat’s Market Potential
3 months ago - By: Yahoo Finance
- Mentions:
MS
CNC
RY
RY.CA
...
Morgan Stanley Sees 8.8% EPS CAGR for Centene (NYSE:CNC), Initiates Coverage with $70 target.
3 months ago - By: Yahoo Finance
- Mentions:
BLND
SNY
NVDA
TSM
...
Covius Services to Acquire Blend Labs’ (BLND) Title365 Holding Co
3 months ago - By: Yahoo Finance
- Mentions:
TTGT
BAC
QCOM
PLD
Craig-Hallum Reiterates a Buy Rating on TechTarget (TTGT)
3 months ago - By: Yahoo Finance
- Mentions:
ELV
ACGL
ARQT
AZN
...
Truist Lowers Elevance Health (ELV) to $500, Keeps Buy Rating
4 months ago - By: Yahoo Finance
- Mentions:
TSLA
AMZN
PINS
AMAT
...
Equity Markets Rise Intraday After Trump-Xi Call; Tesla Slides
Please enable JavaScript to continue using this application.